STLNW Short Volume
Starling Oncology Inc. Wt (STLNW) operates in the Healthcare sector, specifically the Medical - Care Facilities industry, with a market capitalization near $5.6M, listed on NASDAQ, employing roughly 641 people, carrying a beta of 2.56 to the broader market. The Oncology Institute, Inc. Led by Daniel Virnich, public since 2026-08-04.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-08-28
- Short Volume
- 3
- Total Volume
- 6
- Short %
- 50.00%
- 30-Day Avg Short %
- 58.35%
Showing 17 days of FINRA short volume data for Starling Oncology Inc. Wt.
Learn how short volume is reported and how to read the data →
Frequently asked STLNW short volume questions
- What is the daily STLNW short volume?
- As of Aug 28, 2026, Starling Oncology Inc. Wt (STLNW) short volume is 3 shares against 6 total reported volume, or 50.00% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is STLNW short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does STLNW short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.